New Product: Echinacea Ivy – Respiratory and Immune Formula*

November 10, 2020

During uncertain times, it’s important to have access to high quality nutritional supplements. Allergy Research Group® is expanding its already extensive line of immune support products with our new Echinacea Ivy Respiratory and Immune Formula.*

Echinacea Ivy is a blend of EFLA® 894 echinacea (Echinacea purpurea) and ivy (Hedera helix), two botanicals with a long history of traditional use for supporting respiratory tract health.* EFLA® 894 is an advanced 45:1 extract of the dried, cold-pressed juice of freshly harvested blooming flowers of non-GMO Echinacea purpurea, standardized to β-1,2-D-fructofuranosides. EFLA® 894 has clinical and preclinical data suggesting it supports immune system function.*

ResEchinacea Ivy bottleearch suggests EFLA® 894 strengthens immune defenses and promotes a balanced immune response under stress.*

Ivy is a traditional remedy for bronchial irritation and respiratory health, backed by modern research in children and adults.*

Provides 230 mg of EFLA® 894 and 25 mg of ivy per vegetarian capsule.

Free of common allergens and vegan friendly.

To learn more about our products, visit www.allergyresearchgroup.com, or call our customer service team at 1-800-545-9960, extension 2.

CONTACT:
Dan Mallar, National Sales Director
dan.mallar@allergyresearchgroup.com

EFLA® is a registered trademark of Frutarom.

 

*This statement has not been evaluated by the U.S. Food and Drug administration. The product is not intended to diagnose, treat, cure, or prevent any disease.